Matthew Mandeville is a Business Development professional at BrainXell, where he works closely with biotechnology and pharmaceutical partners to support the adoption of human iPSC-derived cell models for neuroscience research and drug discovery. Based in the Greater Boston area, Matt focuses on building collaborative relationships with researchers and organizations seeking physiologically relevant human cell platforms and assay solutions. He brings experience in scientific engagement, customer partnerships, and translating complex research needs into practical solutions that advance translational neuroscience programs.